Pioneer factors in viral infection.
DNA-virus
DUX4
development
herpesvirus
pioneer factor
transcription factor
virus
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
31
08
2023
accepted:
25
09
2023
medline:
26
10
2023
pubmed:
25
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Pioneer factors are transcription factors sharing the fascinating ability to bind to compact chromatin and thereby alter its transcriptional fate. Most pioneer factors are known for their importance during embryonic development, for instance, in inducing zygotic genome activation or cell fate decision. Some pioneer factors are actively induced or downregulated by viral infection. With this, viruses are capable to modulate different signaling pathways resulting for example in MHC-receptor up/downregulation which contributes to viral immune evasion. In this article, we review the current state of research on how different viruses (Herpesviruses, Papillomaviruses and Hepatitis B virus) use pioneer factors for their viral replication and persistence in the host, as well as for the development of viral cancer.
Identifiants
pubmed: 37876935
doi: 10.3389/fimmu.2023.1286617
pmc: PMC10591220
doi:
Substances chimiques
Transcription Factors
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1286617Informations de copyright
Copyright © 2023 Neugebauer, Bastidas-Quintero, Weidl and Full.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Virol. 2019 Jan 17;93(3):
pubmed: 30404794
Front Oncol. 2019 Aug 06;9:713
pubmed: 31448229
J Virol. 2021 Sep 27;95(20):e0076821
pubmed: 34319779
Virology. 2012 Mar 15;424(2):77-98
pubmed: 22284986
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18764-18770
pubmed: 32694203
iScience. 2021 Sep 15;24(10):103132
pubmed: 34632331
BMC Bioinformatics. 2016 Nov 14;17(1):459
pubmed: 27842491
Annu Rev Genet. 2020 Nov 23;54:367-385
pubmed: 32886547
Vitam Horm. 2021;117:101-132
pubmed: 34420577
Nucleic Acids Res. 2013 Jul;41(13):6391-402
pubmed: 23658224
Nat Rev Cancer. 2012 May 04;12(6):381-5
pubmed: 22555282
PLoS Pathog. 2020 Apr 16;16(4):e1008468
pubmed: 32298395
Nat Commun. 2019 Jul 11;10(1):3072
pubmed: 31296853
Infect Agent Cancer. 2014 Jan 20;9(1):3
pubmed: 24438207
J Virol. 2021 Jan 13;95(3):
pubmed: 33148793
Nat Rev Genet. 2019 Apr;20(4):221-234
pubmed: 30573849
J Virol. 2013 Apr;87(8):4261-71
pubmed: 23365437
Elife. 2023 Apr 24;12:
pubmed: 37092726
J Virol. 2008 Aug;82(16):8124-37
pubmed: 18524825
Elife. 2019 Oct 22;8:
pubmed: 31638576
Nucleic Acids Res. 2016 Jun 20;44(11):5161-73
pubmed: 26951377
J Virol. 2020 Oct 27;94(22):
pubmed: 32878886
Elife. 2022 Jan 05;11:
pubmed: 34984978
J Clin Invest. 2020 Jul 1;130(7):3361-3369
pubmed: 32364538
Mol Cell. 2021 Apr 15;81(8):1640-1650
pubmed: 33689750
PLoS Pathog. 2016 Jul 07;12(7):e1005747
pubmed: 27386862
J Virol. 2013 May;87(10):6037-43
pubmed: 23468503
Exp Mol Med. 2015 Jan 23;47:e131
pubmed: 25613728
Proc Natl Acad Sci U S A. 2021 Oct 26;118(43):
pubmed: 34686609
Int J Gynecol Pathol. 2018 Jan;37(1):68-73
pubmed: 28700423
Nat Rev Cancer. 2006 Jan;6(1):11-23
pubmed: 16372018
Nat Rev Mol Cell Biol. 2022 Jul;23(7):449-464
pubmed: 35264768
J Virol. 1995 Jan;69(1):253-62
pubmed: 7983717
Nucleic Acids Res. 2016 Jun 2;44(10):4636-50
pubmed: 26883634
Cell Death Discov. 2023 Apr 8;9(1):118
pubmed: 37031197
Curr Opin Struct Biol. 2021 Dec;71:59-64
pubmed: 34218163
Tumour Biol. 2011 Oct;32(5):941-50
pubmed: 21674242
PLoS Pathog. 2021 Nov 8;17(11):e1010045
pubmed: 34748616
PLoS One. 2013 Oct 23;8(10):e78355
pubmed: 24194922
Nat Commun. 2021 Dec 9;12(1):7153
pubmed: 34887421
Oncogene. 2017 Sep 14;36(37):5252-5262
pubmed: 28481873
Microbiol Spectr. 2023 Feb 14;11(1):e0089822
pubmed: 36475746
Mol Cell. 2023 Apr 20;83(8):1251-1263.e6
pubmed: 36996811
Nat Commun. 2018 Mar 28;9(1):1241
pubmed: 29593314
J Biol Chem. 2018 Sep 7;293(36):13795-13804
pubmed: 29507097
Clinics (Sao Paulo). 2018 Oct 11;73(suppl 1):e558s
pubmed: 30328951
Cell. 2012 Nov 21;151(5):994-1004
pubmed: 23159369
Nat Microbiol. 2019 Jan;4(1):164-176
pubmed: 30420784
Elife. 2019 Mar 19;8:
pubmed: 30888317
Mol Cancer. 2010 Jun 18;9:155
pubmed: 20565867
PLoS Pathog. 2023 Apr 14;19(4):e1011316
pubmed: 37058447
Virchows Arch. 2012 Mar;460(3):271-9
pubmed: 22331131
Arch Virol. 2022 Jan;167(1):109-121
pubmed: 34751815
Virus Res. 2020 Jan 15;276:197808
pubmed: 31712122
J Med Virol. 2023 Mar;95(3):e28676
pubmed: 36929740
Dev Cell. 2019 Sep 9;50(5):658-671.e7
pubmed: 31327741
J Virol. 2018 Aug 16;92(17):
pubmed: 29950413
J Virol. 2021 Jan 28;95(4):
pubmed: 33208447
Blood. 2015 Apr 2;125(14):2228-38
pubmed: 25631773
J Biol Chem. 2021 Jan-Jun;296:100547
pubmed: 33741341
J Virol. 2005 Oct;79(20):12852-60
pubmed: 16188987
Oncogene. 2017 Apr 27;36(17):2435-2445
pubmed: 27797380
Development. 2016 Jun 1;143(11):1833-7
pubmed: 27246709
Front Oncol. 2022 Jul 07;12:900856
pubmed: 35875100
J Gen Virol. 1995 Nov;76 ( Pt 11):2669-78
pubmed: 7595374
J Virol. 2006 Nov;80(22):11191-9
pubmed: 16943287
mBio. 2022 Aug 30;13(4):e0104222
pubmed: 35946797